Clinical Trial

Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 13, 2024 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, a 12-week pragmatic, randomized, double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-08.
Trial Details
NCT Number NCT06633666
Lead Sponsor Hong Kong Baptist University
Conditions Long Covid19, Neuropsychiatric Symptom, Acupuncture
Enrollment 160 participants
Start Date 2023-07-30
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-13